PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8535664-0	1995	Increased LAK and T cell activation in responding renal cell carcinoma patients after low dose cyclophosphamide, IL-2 and alpha-IFN.	Cyclophosphamide	95-111	alpha kinase 1	Homo sapiens	10-13	
1944193-2	1991	LAK/NK activities in PBL from the patients receiving IL-2 plus cyclophosphamide (CY) splenic infusion were much potent than those of the patients receiving IL-2 alone.	Cyclophosphamide	63-79	alpha kinase 1	Homo sapiens	0-3	
1944193-2	1991	LAK/NK activities in PBL from the patients receiving IL-2 plus cyclophosphamide (CY) splenic infusion were much potent than those of the patients receiving IL-2 alone.	Cyclophosphamide	81-83	alpha kinase 1	Homo sapiens	0-3